{"id":"W4353088123","doi":"10.54097/hset.v36i.5576","title":"Single Drug Therapy of PD-1/PD-L1 Checkpoint Inhibitors for Advanced Urothelial Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Highlights in Science Engineering and Technology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"TD Bank Group","funders":"","keywords":"Pembrolizumab; Atezolizumab; Durvalumab; Medicine; Avelumab; Bladder cancer; Oncology; Immunotherapy; Internal medicine; Chemotherapy; Cancer; Lung cancer; Urothelial cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003727164,0.0001746417,0.0005446118,0.0004574249,0.0001550134,0.0004313806,0.0002231947,0.0002598894,0.001686891],"category_scores_gemma":[0.0002263795,0.00006920157,0.0005653256,0.000300119,0.000143114,0.0003785109,0.0002814337,0.0006905473,0.0003943487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003958989,"about_ca_system_score_gemma":0.0004143145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002789997,"about_ca_topic_score_gemma":0.001180256,"domain_scores_codex":[0.9998991,0.00002642166,0.00001047502,0.00001717633,0.00002884458,0.00001794369],"domain_scores_gemma":[0.9999332,0.00001649777,0.00001507693,0.000004265272,0.00001600195,0.00001497653],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001388975,0.0004391516,0.00153418,0.005708598,0.0004107087,0.000428768,0.0000940053,0.001181726,0.03559837,0.003507742,0.0158833,0.9338244],"study_design_scores_gemma":[0.001687029,0.01149442,0.01592142,0.002923451,0.001197086,0.006159772,0.0001618185,0.004627162,0.07511535,0.006587307,0.8740349,0.00009025031],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04851644,0.9388085,0.003693833,0.002037324,0.0006189308,0.00008258433,0.0001931388,0.0001006369,0.005948616],"genre_scores_gemma":[0.4205154,0.564118,0.005936968,0.001514976,0.0005406055,0.0001360129,0.0005947134,0.00002589028,0.006617462],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001686891,"threshold_uncertainty_score":0.005643249,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01444287363552564,"score_gpt":0.2758400711814437,"score_spread":0.261397197545918,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}